Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Maintains Buy on MaxLinear, Lowers Price Target to $50

Needham Maintains Buy on MaxLinear, Lowers Price Target to $50

Needham analyst Quinn Bolton maintains MaxLinear (NASDAQ:MXL) with a Buy and lowers the price target from $53 to $50.

byBenzinga Newsdesk

October 26, 2022

1 minute read

Needham analyst Quinn Bolton maintains MaxLinear (NASDAQ:MXL) with a Buy and lowers the price target from $53 to $50.

Analyst Ratings

Analyst Expectations for Juniper Networks’s Future

By Benzinga Insights

April 26, 1:00 PM

Analysts have provided the following ratings for Juniper Networks (NYSE:JNPR) within the last quarter: Bullish Somewhat Bullish Indifferent…

JNPR

$1000 Invested In Coterra Energy 20 Years Ago Would Be Worth This Much Today

By Benzinga Insights

December 12, 11:34 AM

Coterra Energy (NYSE:CTRA) has outperformed the market over the past 20 years by 5.47% on an annualized basis…

CTRA

Analyst Ratings

What 10 Analyst Ratings Have To Say About Pfizer

By Benzinga Insights

January 26, 8:01 AM

Within the last quarter, Pfizer (NYSE:PFE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

PFE

WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake

By Vandana Singh

May 19, 10:51 AM

An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the

AZN

Needham Maintains Buy on MaxLinear, Lowers Price Target to $50

Related Posts

Analyst Expectations for Juniper Networks’s Future

$1000 Invested In Coterra Energy 20 Years Ago Would Be Worth This Much Today

What 10 Analyst Ratings Have To Say About Pfizer

WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake